CA2618466C - Medicaments destines au diagnostic de l'activite reproductrice tissulaire ou au traitement de maladies proliferatives
- Google Patents
Medicaments destines au diagnostic de l'activite reproductrice tissulaire ou au traitement de maladies proliferatives
Download PDF
Info
Publication number
CA2618466C
CA2618466CCA2618466ACA2618466ACA2618466CCA 2618466 CCA2618466 CCA 2618466CCA 2618466 ACA2618466 ACA 2618466ACA 2618466 ACA2618466 ACA 2618466ACA 2618466 CCA2618466 CCA 2618466C
Authority
CA
Canada
Prior art keywords
compound
hydrogen
radioactive
denotes
substituent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co LtdfiledCriticalNihon Medi Physics Co Ltd
Priority claimed from CA002402991Aexternal-prioritypatent/CA2402991C/fr
Publication of CA2618466A1publicationCriticalpatent/CA2618466A1/fr
Application grantedgrantedCritical
Publication of CA2618466CpublicationCriticalpatent/CA2618466C/fr
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Saccharide Compounds
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
CA2618466A2001-01-232002-01-22Medicaments destines au diagnostic de l'activite reproductrice tissulaire ou au traitement de maladies proliferatives
Expired - Fee RelatedCA2618466C
(fr)
Preparation of Nucleosides Derived from 2-Nitroimidazole and d-Arabinose, d-Ribose, and d-Galactose by the Vorbrüggen Method and Their Conversion to Potential Precursors for Tracers To Image Hypoxia
Relation between structure and brain uptake of carbon-11 labeled acyclic and furo [2, 3-d] pyrimidine-derivatives of bicyclic nucleoside analogues (BCNAs)
PRODUCTION DU 1-($g(b)-D-ARABINOFURANOSYL)-5(E)-(2-IODOVINYL)URACIL ET SES UTILISATIONS, AINSI QUE DES ANALOGUES ASSOCIES RENFERMANT D'AUTRES RADIONUCLIDES HALOGENES, LES PRECURSEURS GENERAUX DE RADIOHALOGENATION, 1-(2,3,5-TRI-O-ACETYL-$g(b)-D-ARABINOFURANOSYL)-5(Z ET E)-(2-TRIMETHYLSILYLVINYL)URACI